Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2023 |
Parham GP, Egemen D, Befano B, Mwanahamuntu MH, Rodriguez AC, Antani S, Chisele S, Munalula MK, Kaunga F, Musonda F, Malyangu E, Shibemba AL, de Sanjose S, Schiffman M, Sahasrabuddhe VV. Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation. Infectious Agents and Cancer. 18: 61. PMID 37845724 DOI: 10.1186/s13027-023-00536-5 |
0.01 |
|
2023 |
Einstein MH, Zhou N, Gabor L, Sahasrabuddhe VV. Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening. Obstetrics and Gynecology. PMID 37708516 DOI: 10.1097/AOG.0000000000005393 |
0.01 |
|
2023 |
Hu L, Mwanahamuntu MH, Sahasrabuddhe VV, Barrett C, Horning MP, Shah I, Laverriere Z, Banik D, Ji Y, Shibemba AL, Chisele S, Munalula MK, Kaunga F, Musonda F, Malyangu E, et al. Validation of Automated Visual Evaluation (AVE) on Smartphone Images for Cervical Cancer Screening in a Prospective Study in Zambia. Medrxiv : the Preprint Server For Health Sciences. PMID 37560093 DOI: 10.1101/2023.07.19.23292888 |
0.01 |
|
2023 |
Desravines N, Hsu CH, Mohnot S, Sahasrabuddhe V, House M, Sauter E, O'Connor S, Bauman JE, Chow HS, Rahangdale L. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 37431689 DOI: 10.1002/ijgo.14983 |
0.01 |
|
2023 |
Rodrigues LLS, Pilotto JH, Martinelli KG, Nicol AF, De Paula VS, Gheit T, Oliveira NSC, Silva-de-Jesus C, Sahasrabuddhe VV, Da Silva DM, Kast WM, Hardick J, Gaydos CA, Morgado MG. Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil. Viruses. 15. PMID 37376627 DOI: 10.3390/v15061328 |
0.01 |
|
2023 |
Zeng Y, Moscicki AB, Woo H, Hsu CH, Kemp TJ, Pinto LA, Szabo E, Dimond E, Bauman J, Sahasrabuddhe VV, Chow HS. HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine. Pediatrics. PMID 37317810 DOI: 10.1542/peds.2022-060301 |
0.01 |
|
2023 |
Eickhoff J, Zaborek J, Chen G, Sahasrabuddhe VV, Ford LG, Szabo E, Kim K. A systematic review and pooled analysis of hypothesized versus observed effect sizes in early phase cancer prevention clinical trials. Cancer Prevention Research (Philadelphia, Pa.). PMID 37258421 DOI: 10.1158/1940-6207.CAPR-23-0060 |
0.01 |
|
2022 |
Samimi G, House M, Benante K, Bengtson L, Budd T, Dermody B, DeShong K, Dyer V, Kimler BF, Sahasrabuddhe VV, Siminski S, Ford LG, Vilar E, Szabo E. Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs. Cancer Prevention Research (Philadelphia, Pa.). 15: 279-284. PMID 35502553 DOI: 10.1158/1940-6207.CAPR-21-0578 |
0.01 |
|
2022 |
Sahasrabuddhe VV, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Arbyn M. Reply to: Comments on 'Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening'. International Journal of Cancer. PMID 35377490 DOI: 10.1002/ijc.34013 |
0.01 |
|
2022 |
Wilkin T, Chen H, Sahasrabuddhe V, Matining R, Mngqibisa R, Chinula L, Mbilizi Y, Magure T, Omoz-Oarhe AE, Rassool M, Riviere C, Bhosale R, Godbole S, Naranjo R, Coombs R, et al. A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35294524 DOI: 10.1093/cid/ciac213 |
0.01 |
|
2022 |
Arbyn M, Latsuzbaia A, Castle PE, Sahasrabuddhe VV, Broeck DV. HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer. The Lancet Regional Health. Europe. 14: 100332. PMID 35243475 DOI: 10.1016/j.lanepe.2022.100332 |
0.01 |
|
2022 |
Arbyn M, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Sahasrabuddhe VV. Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening. International Journal of Cancer. PMID 35179777 DOI: 10.1002/ijc.33967 |
0.01 |
|
2021 |
Desai KT, Befano B, Xue Z, Kelly H, Campos N, Egemen D, Gage J, Rodriguez AC, Sahasrabuddhe V, Levitz D, Pearlman P, Jeronimo J, Antani S, Schiffman M, de Sanjose S. The development of "Automated Visual Evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing. International Journal of Cancer. PMID 34800038 DOI: 10.1002/ijc.33879 |
0.01 |
|
2021 |
Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. Ca: a Cancer Journal For Clinicians. PMID 34499351 DOI: 10.3322/caac.21696 |
0.01 |
|
2020 |
Litwin TR, Irvin SR, Chornock RL, Sahasrabuddhe VV, Stanley M, Wentzensen N. Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis. British Journal of Cancer. PMID 33257839 DOI: 10.1038/s41416-020-01184-x |
0.01 |
|
2019 |
Zeng Y, Moscicki AB, Sahasrabuddhe VV, Garcia F, Woo H, Hsu CH, Szabo E, Dimond E, Vanzzini S, Mondragon A, Butler V, DeRose H, Chow HS. A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol. Bmc Cancer. 19: 290. PMID 30935375 DOI: 10.1186/S12885-019-5444-4 |
0.01 |
|
2018 |
Chinula L, Hicks M, Chiudzu G, Tang JH, Gopal S, Tomoka T, Kachingwe J, Pinder L, Hicks M, Sahasrabuddhe V, Parham G. A tailored approach to building specialized surgical oncology capacity: Early experiences and outcomes in Malawi. Gynecologic Oncology Reports. 26: 60-65. PMID 30364674 DOI: 10.1016/j.gore.2018.10.001 |
0.01 |
|
2018 |
Pinder LF, Henry-Tillman R, Linyama D, Kusweje V, Nzayisenga JB, Shibemba A, Sahasrabuddhe V, Lishimpi K, Mwanahamuntu M, Hicks M, Parham GP. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. Journal of Global Oncology. 1-8. PMID 30241176 DOI: 10.1200/JGO.17.00026 |
0.01 |
|
2018 |
Rodrigues LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, Oliveira NS, Chavez-Juan E, Da Silva DM, Kast WM, Nicol AF, Pilotto JH. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors. Gynecologic Oncology. PMID 30087059 DOI: 10.1016/J.Ygyno.2018.08.004 |
0.01 |
|
2018 |
Silkensen SL, Schiffman M, Sahasrabuddhe V, Flanigan JS. Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening? Global Health, Science and Practice. 6: 242-246. PMID 29959268 DOI: 10.9745/Ghsp-D-18-00206 |
0.01 |
|
2018 |
Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, Vorkoper S, Pastakia SD, Rausch D, Levitt NS. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. Aids (London, England). 32: S5-S20. PMID 29952786 DOI: 10.1097/Qad.0000000000001888 |
0.01 |
|
2018 |
Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 516: 86-101. PMID 29331867 DOI: 10.1016/J.Virol.2018.01.002 |
0.01 |
|
2017 |
Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, Ford LG. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia. PMID 28776080 DOI: 10.1007/s00125-017-4372-6 |
0.01 |
|
2017 |
Lee S, Sahasrabuddhe VV, Mendoza-Cervantes D, Zhao R, Duggan MA. Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 28582347 DOI: 10.1097/PGP.0000000000000406 |
0.01 |
|
2016 |
Mane A, Sahasrabuddhe VV, Nirmalkar A, Risbud AR, Sahay S, Bhosale RA, Vermund SH, Mehendale SM. Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 88: 26-32. PMID 28152432 DOI: 10.1016/J.Jcv.2016.10.013 |
0.01 |
|
2016 |
Lee S, Rose MS, Sahasrabuddhe VV, Zhao R, Duggan MA. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 27801764 DOI: 10.1097/PGP.0000000000000345 |
0.01 |
|
2016 |
Campbell PT, Newton CC, Freedman ND, Koshiol J, Alavanja MC, Beane Freeman LE, Buring JE, Chan AT, Chong DQ, Datta M, Gaudet MM, Gaziano JM, Giovannucci EL, Graubard BI, Hollenbeck AR, ... ... Sahasrabuddhe VV, et al. Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Research. 76: 6076-6083. PMID 27742674 DOI: 10.1158/0008-5472.Can-16-0787 |
0.01 |
|
2016 |
Yang B, Petrick JL, Chen J, Hagberg KW, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA. Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer Epidemiology. 43: 105-111. PMID 27420633 DOI: 10.1016/J.Canep.2016.06.009 |
0.01 |
|
2016 |
Yang B, Hagberg KW, Chen J, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA. Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink. British Journal of Cancer. PMID 27219020 DOI: 10.1038/Bjc.2016.148 |
0.01 |
|
2016 |
Hagberg KW, Sahasrabuddhe VV, McGlynn KA, Jick SS. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the UK Clinical Practice Research Datalink. Pharmacotherapy. PMID 26846893 DOI: 10.1002/Phar.1704 |
0.01 |
|
2016 |
Yang B, Yang HP, Ward KK, Sahasrabuddhe VV, McGlynn KA. Bariatric Surgery and Liver Cancer in a Consortium of Academic Medical Centers. Obesity Surgery. PMID 26757918 DOI: 10.1007/s11695-016-2051-1 |
0.01 |
|
2016 |
Parham GP, Mwanahamuntu MH, Hicks ML, Henry-Tillman R, Chibwesha CJ, Chinula L, Oneko OA, Murokora D, Sahasrabuddhe VV. Population-level scale-up of surgery platforms for women's cancer care in low- and middle-income countries Journal of Cancer Policy. 7: 23-27. DOI: 10.1016/j.jcpo.2015.12.002 |
0.01 |
|
2015 |
Ramautarsing RA, Phanuphak N, Chaithongwongwatthana S, Wit FW, Teeratakulpisarn N, Pankam T, Rodbamrung P, Wijgert JH, Lange JM, Phanuphak P, Sahasrabuddhe VV, Kerr S, Ananworanich J. Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand. Journal of Virus Eradication. 1: 96-102. PMID 27482398 |
0.01 |
|
2015 |
McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI, Sunaya N, Jick S, Sahasrabuddhe VV. Menopausal hormone therapy use and risk of primary liver cancer in the Clinical Practice Research Datalink. International Journal of Cancer. Journal International Du Cancer. PMID 26662112 DOI: 10.1002/Ijc.29960 |
0.01 |
|
2015 |
Petrick JL, Sahasrabuddhe VV, Chan AT, Alavanja MC, Beane Freeman LE, Buring JE, Chen J, Chong DQ, Freedman ND, Fuchs CS, Gaziano JM, Giovannucci EL, Graubard BI, Hollenbeck AR, Hou L, et al. NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prevention Research (Philadelphia, Pa.). PMID 26391917 DOI: 10.1158/1940-6207.Capr-15-0126 |
0.01 |
|
2015 |
Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. Journal of Acquired Immune Deficiency Syndromes (1999). 70: e20-6. PMID 26322673 DOI: 10.1097/Qai.0000000000000685 |
0.01 |
|
2015 |
Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. Bmc Cancer. 15: 541. PMID 26205980 DOI: 10.1186/s12885-015-1558-5 |
0.01 |
|
2015 |
Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, Alavanja MC, Beane Freeman LE, Boggs DA, Buring JE, Chan AT, Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, et al. Coffee consumption and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma by sex: The Liver Cancer Pooling Project. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26126626 DOI: 10.1158/1055-9965.Epi-15-0137 |
0.01 |
|
2015 |
Katundu K, Bateman AC, Pfaendler KS, Mwanahamuntu MH, Kapambwe S, Vermund SH, Sahasrabuddhe VV, Msadabwe SC, Stringer JS, Parham GP, Chibwesha CJ. The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. Journal of Lower Genital Tract Disease. PMID 26125097 DOI: 10.1097/Lgt.0000000000000131 |
0.01 |
|
2015 |
McCree R, Giattas MR, Sahasrabuddhe VV, Jolly PE, Martin MY, Usdan SL, Kohler C, Lisovicz N. Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up. The Oncologist. 20: 621-6. PMID 25926351 DOI: 10.1634/Theoncologist.2013-0305 |
0.01 |
|
2015 |
Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, ... ... Sahasrabuddhe VV, et al. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. Plos One. 10: e0122169. PMID 25885821 DOI: 10.1371/Journal.Pone.0122169 |
0.01 |
|
2015 |
McGlynn KA, Sahasrabuddhe VV, Campbell PT, Graubard BI, Chen J, Schwartz LM, Petrick JL, Alavanja MC, Andreotti G, Boggs DA, Buring JE, Chan AT, Freedman ND, Gapstur SM, Hollenbeck AR, et al. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project. British Journal of Cancer. 112: 1266-72. PMID 25742475 DOI: 10.1038/Bjc.2015.58 |
0.01 |
|
2015 |
McGlynn KA, Hagberg K, Chen J, Graubard BI, London WT, Jick S, Sahasrabuddhe VV. Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink. Journal of the National Cancer Institute. 107. PMID 25722350 DOI: 10.1093/Jnci/Djv009 |
0.01 |
|
2015 |
Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. Journal of the National Cancer Institute. 107. PMID 25650316 DOI: 10.1093/Jnci/Dju436 |
0.01 |
|
2015 |
Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JSA, Parham GP, Chibwesha CJ. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: A modeling study Bmc Cancer. 15. DOI: 10.1186/s12885-015-1558-5 |
0.01 |
|
2015 |
Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JSA, Parham GP. Implementation and operational research: Age distribution and determinants of invasive cervical cancer in a "Screen-and-Treat" program integrated With HIV/AIDS care in Zambia Journal of Acquired Immune Deficiency Syndromes. 70: e20-e26. DOI: 10.1097/QAI.0000000000000685 |
0.01 |
|
2014 |
Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. Virology Journal. 11: 202. PMID 25481842 DOI: 10.1186/s12985-014-0202-3 |
0.01 |
|
2014 |
McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, Yood MU, Alford SH. Statin use and risk of hepatocellular carcinoma in a U.S. population. Cancer Epidemiology. 38: 523-7. PMID 25113938 DOI: 10.1016/J.Canep.2014.06.009 |
0.01 |
|
2014 |
Hagberg KW, Mcglynn KA, Sahasrabuddhe VV, Jick S. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes British Journal of Cancer. 111: 1710-1717. PMID 25093492 DOI: 10.1038/Bjc.2014.447 |
0.01 |
|
2014 |
Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 212-5. PMID 24977474 DOI: 10.1097/Qai.0000000000000270 |
0.01 |
|
2014 |
Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. Journal of Clinical Microbiology. 52: 2892-7. PMID 24899025 DOI: 10.1128/JCM.03517-13 |
0.01 |
|
2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 414-7. PMID 24881489 DOI: 10.1016/J.Jcv.2014.04.016 |
0.01 |
|
2014 |
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 126: 88-9. PMID 24810795 DOI: 10.1016/J.Ijgo.2014.01.006 |
0.01 |
|
2014 |
Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. The Journal of Infectious Diseases. 210: 448-55. PMID 24569064 DOI: 10.1093/Infdis/Jiu104 |
0.01 |
|
2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Journal of Clinical Microbiology. 52: 187-92. PMID 24197879 DOI: 10.1128/Jcm.01623-13 |
0.01 |
|
2013 |
De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 31: F32-46. PMID 24331746 DOI: 10.1016/j.vaccine.2012.07.092 |
0.01 |
|
2013 |
Godfrey Dr. CC, Michelow PM, Godard M, Sahasrabuddhe VV, Darden J, Firnhaber CS, Wetherall NT, Bremer J, Coombs RW, Wilkin T. Improving diagnostic capability for HPV disease internationally within the NIH-NIAID division of AIDS clinical trial networks American Journal of Clinical Pathology. 140: 881-889. PMID 24225757 DOI: 10.1309/AJCPIBIS19QIYHJY |
0.01 |
|
2013 |
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. Plos One. 8: e74607. PMID 24058599 DOI: 10.1371/Journal.Pone.0074607 |
0.01 |
|
2013 |
Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. Plos One. 8: e72565. PMID 23977318 DOI: 10.1371/Journal.Pone.0072565 |
0.01 |
|
2013 |
Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N. Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. The Journal of Infectious Diseases. 208: 1768-75. PMID 23908478 DOI: 10.1093/infdis/jit374 |
0.01 |
|
2013 |
Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA. Response. Journal of the National Cancer Institute. 105: 668- 71. PMID 23767058 DOI: 10.1093/jnci/djt063 |
0.01 |
|
2013 |
Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. International Journal of Cancer. Journal International Du Cancer. 133: 2172-81. PMID 23588935 DOI: 10.1002/Ijc.28215 |
0.01 |
|
2013 |
Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. The Journal of Infectious Diseases. 207: 392-401. PMID 23162133 DOI: 10.1093/infdis/jis694 |
0.01 |
|
2012 |
Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. Journal of the National Cancer Institute. 104: 1808-14. PMID 23197492 DOI: 10.1093/Jnci/Djs452 |
0.01 |
|
2012 |
Sahasrabuddhe VV, Sherman ME. Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. Journal of the National Cancer Institute. 104: 1698-701. PMID 23104325 DOI: 10.1093/jnci/djs453 |
0.01 |
|
2012 |
Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. Aids (London, England). 26: 2185-92. PMID 23018436 DOI: 10.1097/QAD.0b013e328359f255 |
0.01 |
|
2012 |
Sahasrabuddhe VV, Shiels MS, McGlynn KA, Engels EA. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 118: 6226-33. PMID 22736272 DOI: 10.1002/Cncr.27694 |
0.01 |
|
2012 |
Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. Plos One. 7: e38731. PMID 22723879 DOI: 10.1371/Journal.Pone.0038731 |
0.01 |
|
2012 |
Brinton LA, Sahasrabuddhe VV, Scoccia B. Fertility drugs and the risk of breast and gynecologic cancers. Seminars in Reproductive Medicine. 30: 131-45. PMID 22549713 DOI: 10.1055/s-0032-1307421 |
0.01 |
|
2012 |
Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, Smith JS, Jiang CQ, Mei RB, Wang XG, Li ZA, Qiao YL. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 91-6. PMID 22502720 DOI: 10.7314/APJCP.2012.13.1.091 |
0.01 |
|
2012 |
Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prevention Research (Philadelphia, Pa.). 5: 11-7. PMID 22158053 DOI: 10.1158/1940-6207.Capr-11-0540 |
0.01 |
|
2012 |
Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. International Journal of Cancer. Journal International Du Cancer. 130: 234-40. PMID 21387289 DOI: 10.1002/Ijc.25971 |
0.01 |
|
2011 |
Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiology. 6: 1083-98. PMID 21958146 DOI: 10.2217/fmb.11.87 |
0.01 |
|
2011 |
Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. Plos One. 6: e20183. PMID 21673791 DOI: 10.1371/Journal.Pone.0020183 |
0.01 |
|
2011 |
Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. Plos Medicine. 8: e1001032. PMID 21610859 DOI: 10.1371/Journal.Pmed.1001032 |
0.01 |
|
2010 |
Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C, Pfaendler KS, Mkumba G, Mudenda V, Kapambwe S, Vermund SH, Hicks ML, Stringer JS, Chi BH. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. Hiv Therapy. 4: 703-722. PMID 25419240 DOI: 10.2217/Hiv.10.52 |
0.01 |
|
2010 |
Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Pfaendler K, Parham G. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Global Health Promotion. 17: 47-50. PMID 20595342 DOI: 10.1177/1757975910363938 |
0.01 |
|
2010 |
Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. Journal of Lower Genital Tract Disease. 14: 167-73. PMID 20592550 DOI: 10.1097/LGT.0b013e3181cd6d5e |
0.01 |
|
2010 |
Bratcher LF, Sahasrabuddhe VV. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infectious Agents and Cancer. 5: 8. PMID 20462441 DOI: 10.1186/1750-9378-5-8 |
0.01 |
|
2010 |
Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. Plos One. 5: e8634. PMID 20072610 DOI: 10.1371/Journal.Pone.0008634 |
0.01 |
|
2009 |
Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP. HPV screening for cervical cancer in rural India. The New England Journal of Medicine. 361: 305; author reply 30. PMID 19610158 |
0.01 |
|
2009 |
Li AH, Phanuphak N, Sahasrabuddhe VV, Chaithongwongwatthana S, Vermund SH, Jenkins CA, Shepherd BE, Teeratakulpisarn N, Van Der Lugt J, Avihingsanon A, Ruxrungtham K, Shikuma C, Phanuphak P, Ananworanich J. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand Sexually Transmitted Infections. 85: 503-507. PMID 19525263 DOI: 10.1136/Sti.2009.036707 |
0.01 |
|
2009 |
Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. Aids (London, England). 23: N1-5. PMID 19279439 DOI: 10.1097/Qad.0B013E3283236E11 |
0.01 |
|
2009 |
Sahasrabuddhe VV, Vermund SH. Current and futuretrends: implicationsfor HIV prevention Hiv Prevention. 9.11-9.30. DOI: 10.1016/B978-0-12-374235-3.00001-7 |
0.01 |
|
2008 |
Joshi SN, Das S, Thakar M, Sahasrabuddhe V, Kumar BK, Callahan M, Mauck C. Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle. Journal of Lower Genital Tract Disease. 12: 293-9. PMID 18820544 DOI: 10.1097/LGT.0b013e31817efbbd |
0.01 |
|
2008 |
Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bulletin of the World Health Organization. 86: D-E. PMID 18797604 |
0.01 |
|
2008 |
Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecologic Oncology. 110: 402-7. PMID 18556050 DOI: 10.1016/j.ygyno.2008.04.031 |
0.01 |
|
2008 |
Vermund SH, Sahasrabuddhe VV, Khedkar S, Jia Y, Etherington C, Vergara A. Building global health through a center-without-walls: the Vanderbilt Institute for Global Health. Academic Medicine : Journal of the Association of American Medical Colleges. 83: 154-64. PMID 18303361 DOI: 10.1097/Acm.0B013E318160B76C |
0.01 |
|
2008 |
Sahasrabuddhe V, Mehendale S. Female sex workers and the HIV/AIDS epidemic in India Prostitution and Beyond: An Analysis of Sex Work in India. 239-260. DOI: 10.4135/9788132100362.n17 |
0.01 |
|
2007 |
Sahasrabuddhe VV, Vermund SH. The future of HIV prevention: control of sexually transmitted infections and circumcision interventions. Infectious Disease Clinics of North America. 21: 241-57, xi. PMID 17502238 DOI: 10.1016/J.Idc.2007.03.005 |
0.01 |
|
2007 |
Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. British Journal of Cancer. 96: 1480-3. PMID 17437020 DOI: 10.1038/Sj.Bjc.6603737 |
0.01 |
|
2006 |
Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecologic Oncology. 103: 1017-22. PMID 16875716 DOI: 10.1016/J.Ygyno.2006.06.015 |
0.01 |
|
2005 |
Sahasrabuddhe V, Makhija S. Double jeopardy: HIV and cervical cancer in Indian women International Journal of Gynecological Cancer. 15: 1-3. PMID 15670289 DOI: 10.1111/j.1048-891X.2005.15001.x |
0.01 |
|
2002 |
Sahasrabuddhe VV, Gholap TA, Jethava YS, Joglekar NS, Brahme RG, Gaikwad BA, Wankhede AK, Mehendale SM. Patient-led partner referral in a district hospital based STD clinic Journal of Postgraduate Medicine. 48: 105-108. PMID 12215690 |
0.01 |
|
Hide low-probability matches. |